These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2192105)

  • 1. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H; Sakawaki T
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K; Mitsuhashi F; Ohkura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A; Hinoda Y; Imai K; Endo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 9. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
    DelVillano BC; Zurawski VR
    Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of CA 130 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NCC-ST-439].
    Sugano K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N; Satomura Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of CA125 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Kuzuya K
    Nihon Rinsho; 1990 Feb; 48 Suppl():978-81. PubMed ID: 2192183
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on the clinical usefulness of NCC-ST-439 in breast cancer].
    Takahashi H; Nakanishi K; Taguchi K; Hasumi T; Hamada H; Sasaki F; Hata Y; Uchino J
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):245-9. PubMed ID: 1992918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.